Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo

Antigen mannosylation has been shown to be an effective approach to potentiate antigen immunogenicity, due to the enhanced antigen uptake and presentation by APC. To overcome disadvantages associated with conventional methods used to mannosylate antigens, we have developed a novel mannose‐based antigen delivery system that utilizes a polyamidoamine (PAMAM) dendrimer. It is demonstrated that mannosylated dendrimer ovalbumin (MDO) is a potent immune inducer. With a strong binding avidity to DC, MDO potently induced OVA‐specific T cell response in vitro. It was found that the immunogenicity of MDO was due not only to enhanced antigen presentation, but also to induction of DC maturation. Mice immunized with MDO generated strong OVA‐specific CD4+/CD8+ T cell and antibody responses. MDO also targeted lymph node DC to cross‐present OVA, leading to OTI CD8+ T cell proliferation. Moreover, upon challenge with B16‐OVA tumor cells, tumors in mice pre‐immunized with MDO either did not grow or displayed a much more delayed onset, and had slower kinetics of growth than those of OVA‐immunized mice. This mannose‐based antigen delivery system was applied here for the first time to the immunization study. With several advantages and exceptional adjuvanticity, we propose mannosylated dendrimer as a potential vaccine carrier.

[1]  S. Levitz,et al.  Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. , 2007, Vaccine.

[2]  P. Jensen.  Faculty Opinions recommendation of The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. , 2007 .

[3]  V. Apostolopoulos,et al.  Receptor-mediated delivery of antigens to dendritic cells: anticancer applications. , 2007, Molecular pharmaceutics.

[4]  R. Steinman,et al.  Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.

[5]  R. Yung,et al.  Effect of aging on bone marrow-derived murine CD11c+CD4-CD8alpha- dendritic cell function. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[6]  G. Belz,et al.  The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Wright,et al.  Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells , 2006, Immunology.

[8]  V. Apostolopoulos,et al.  Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] , 2006, Breast Cancer Research.

[9]  V. Lukacs-Kornek,et al.  The Mannose Receptor Mediates Uptake of Soluble but Not of Cell-Associated Antigen for Cross-Presentation1 , 2006, The Journal of Immunology.

[10]  C. Specht,et al.  The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. , 2006, FEMS yeast research.

[11]  Javier Rojo,et al.  Mannose hyperbranched dendritic polymers interact with clustered organization of DC‐SIGN and inhibit gp120 binding , 2006, FEBS letters.

[12]  C. Specht,et al.  A Model Vaccine Exploiting Fungal Mannosylation to Increase Antigen Immunogenicity1 , 2005, The Journal of Immunology.

[13]  J. Wang,et al.  Enhanced Maturation and Functional Capacity of Dendritic Cells Induced by Mannosylated L2 Domain of ErbB2 Receptor , 2005, Scandinavian journal of immunology.

[14]  D. Pietrella,et al.  Mannoproteins from Cryptococcus neoformans Promote Dendritic Cell Maturation and Activation , 2005, Infection and Immunity.

[15]  K. Knutson,et al.  Tumor antigen-specific T helper cells in cancer immunity and immunotherapy , 2005, Cancer Immunology, Immunotherapy.

[16]  S. Gordon,et al.  Ligand recognition by antigen-presenting cell C-type lectin receptors , 2004, Current Opinion in Immunology.

[17]  H. Ikeda,et al.  The critical role of type‐1 innate and acquired immunity in tumor immunotherapy , 2004, Cancer science.

[18]  J. M. Benito,et al.  Optimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimer-cyclodextrin conjugates. , 2004, Journal of the American Chemical Society.

[19]  B. Lin,et al.  Analysis of chicken and turkey ovalbumins by microchip electrophoresis combined with exoglycosidase digestion , 2003, Electrophoresis.

[20]  N. McKeown,et al.  The influence of surface modification on the cytotoxicity of PAMAM dendrimers. , 2003, International journal of pharmaceutics.

[21]  V. Apostolopoulos,et al.  Use of the Mannan Receptor to Selectively Target Vaccine Antigens for Processing and Antigen Presentation through the MHC Class I and Class II Pathways , 2002, Annals of the New York Academy of Sciences.

[22]  Antonio Lanzavecchia,et al.  The Dendritic Cell-Specific Adhesion Receptor DC-SIGN Internalizes Antigen for Presentation to T Cells1 , 2002, The Journal of Immunology.

[23]  R. Steinman,et al.  Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. , 2001, International immunology.

[24]  E. Schaftingen,et al.  High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival. , 2001, Cancer research.

[25]  G. Pietersz,et al.  Mannan Mucin-1 Peptide Immunization: Influence of Cyclophosphamide and the Route of Injection , 2001, Journal of immunotherapy.

[26]  M. Bevan,et al.  Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo , 2000, The Journal of experimental medicine.

[27]  M. Merad,et al.  Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo , 2000 .

[28]  V. Apostolopoulos,et al.  Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. , 2000, Vaccine.

[29]  V. Apostolopoulos,et al.  A role for IL‐5 in the induction of cytotoxic T lymphocytes in vivo , 2000, European journal of immunology.

[30]  V. Apostolopoulos,et al.  Aldehyde‐mannan antigen complexes target the MHC class I antigen‐presentation pathway , 2000, European journal of immunology.

[31]  K. Drickamer.  C-type lectin-like domains. , 1999, Current opinion in structural biology.

[32]  J. Drijfhout,et al.  Strongly increased efficiency of altered peptide ligands by mannosylation. , 1998, International immunology.

[33]  T. Kortemme,et al.  Ionization-reactivity relationships for cysteine thiols in polypeptides. , 1998, Biochemistry.

[34]  V. Apostolopoulos,et al.  Parameters for using mannan-MUC1 fusion protein to induce cellular immunity , 1998, Cancer Immunology, Immunotherapy.

[35]  V. Apostolopoulos,et al.  Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. , 1997, The Journal of clinical investigation.

[36]  V. Apostolopoulos,et al.  Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen. , 1997, Vaccine.

[37]  A. Lanzavecchia,et al.  The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells , 1997, European journal of immunology.

[38]  J. Drijfhout,et al.  Mannose receptor‐mediated uptake of antigens strongly enhances HLA class II‐restricted antigen presentation by cultured dendritic cells , 1997, European journal of immunology.

[39]  M. Bevan,et al.  Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. , 1997, Blood.

[40]  F. Koning.  Enhancement of HLA class II restricted antigen presentation by mannose-receptor-mediated uptake. , 1997, Biochemical Society transactions.

[41]  V. Apostolopoulos,et al.  Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Monsigny,et al.  Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod. , 1988, Analytical biochemistry.

[43]  J Carlsson,et al.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. , 1978, The Biochemical journal.

[44]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[45]  M. Merad,et al.  Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo. , 2000, Blood.